Initiation of Buprenorphine in Outpatient Settings

Initiation of Buprenorphine in Outpatient Settings

This training presents a range of evidence-based strategies for initiating buprenorphine treatment within ambulatory care practices. Special attention is directed towards effective measures supporting the transition of patients using illicitly manufactured fentanyl onto prescribed buprenorphine.

NOTE: This training is 60 minutes long. There will be an optional 30-minute Q&A session following the training, which will not count for credit.

Learning Objectives

• Describe the prevalence of illicitly manufactured fentanyl in the US drug supply.
• Explain the major pharmacologic properties of both fentanyl and buprenorphine.
• Recall at least two “tools” that can help guide the process of starting buprenorphine treatment.
• Identify at least three medications that have been proven to support management of withdrawal symptoms during the buprenorphine initiation process.

Learn more & register 

For trainings that indicate Continuing Education Units (CEUs) are available, contact the organizer and/or the Vermont Office of Professional Regulation to verify that the credits will count toward the continuing education requirements of your licensure or certification.